Internal Medicine Alert – September 15, 2012
September 15, 2012
View Issues
-
Grape Resveratrol in the Primary Prevention of Cardiovascular Disease
Supplemental grape resveratrol appears to improve both inflammatory and fibrinolytic markers in patients who are on statin therapy for primary prevention of cardiovascular disease. -
Brief Report: When Pneumonia Occurs with Flu: Think Influenza
CASES OF PANDEMIC H1N1 REQUIRING HOSPITALIZATION were examined by reviewing two national case series from spring and fall 2009 -
Patient Attitudes Toward Treatments for Overactive Bladder
Women with overactive bladder hold differing views of their treatment options in light of the severity of their symptoms as well as the risks/benefits of the modality. -
In-Home HIV Test Empowers Patients
The OraQuick in-home HIV-1/2 antibody test was granted market clearance by the FDA on May 15, 2012. Data presented included a < 0.1% false-positive rate and 91.7% sensitivity to correctly detect HIV infection compared to conventional ELISA performed on blood. -
Pharmacology Update
THE FDA HAS APPROVED A NEW FORMULATION OF PREDNISONE for the treatment rheumatoid arthritis and other conditions in which an anti-inflammatory or immuosuppressive agent is indicated. -
Clinical Briefs
Clinical Briefs: Refining the Relationship Between Thyroid Hormones and Left Ventricular Mass; The ORIGIN Trial: Basal Insulin vs Standard Care for Early Type 2 Diabetes; Bronchodilators in COPD and Arrhythmias -
CME Objectives/CME Questions
-
ECG Review
The 12-lead ECG shown above was obtained from an older woman who was extremely anxious about her home situation. She felt some "heart sensations." Is she in atrial fibrillation?